Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 16.30% in the past year Substantial increase in net sales/revenue by 1.93%.
- Income over the Year and quarter: There has been decline in other income over the past year which is -81.06% Marginal decrease of -83.81% in other income during this quarter
- Profit over the Year and quarter: Significant improvement in profitability for ROSSARI BIOTECH LIMITED. Notable increase of 17.78% in net profit Year to YearROSSARI BIOTECH LIMITED’s profitability dropped by -0.75% Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 17.71% Year to Year.EPS decreased by -0.80%. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 406.47 Cr | Rs. 463.77 Cr | Rs. 472.72 Cr | + 1.93% | + 16.3% |
Expenses | Rs. 351.88 Cr | Rs. 400.1 Cr | Rs. 409.13 Cr | + 2.26% | + 16.27% |
Operating Profit | Rs. 54.59 Cr | Rs. 63.67 Cr | Rs. 63.59 Cr | -0.13% | + 16.49% |
OPM % | 13.43 % | 13.73 % | 13.45 % | -0.28% | + 0.02% |
Other Income | Rs. 3.01 Cr | Rs. 3.52 Cr | Rs. 0.57 Cr | -83.81% | -81.06% |
Interest | Rs. 4.35 Cr | Rs. 4.32 Cr | Rs. 2.52 Cr | -41.67% | -42.07% |
Depreciation | Rs. 16.02 Cr | Rs. 15.09 Cr | Rs. 16.07 Cr | + 6.49% | + 0.31% |
Profit before tax | Rs. 37.23 Cr | Rs. 47.78 Cr | Rs. 45.57 Cr | -4.63% | + 22.4% |
Tax % | 22.29 % | 28.04 % | 25.2 % | -2.84% | + 2.91% |
Net Profit | Rs. 28.98 Cr | Rs. 34.39 Cr | Rs. 34.13 Cr | -0.76% | + 17.77% |
EPS in Rs | Rs. 5.25 | Rs. 6.23 | Rs. 6.18 | -0.8% | + 17.71% |
Today, we’re looking at ROSSARI BIOTECH LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 16.3%. However, it did see a marginal increase of 1.93% from the previous quarter.Expenses ticked up slightly by 2.26% quarter-on-quarter, aligning with the annual rise of 16.27%. Operating profit, while up 16.49% compared to last year, faced a quarter-on-quarter dip of -0.13%, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.02%, but a shrinkage of -0.28% sequentially. Other income fell by -83.81% compared to the last quarter, despite an annual decline of -81.06%. Interest expenses dropped significantly by -41.67% from the previous quarter, yet the year-over-year decrease remains at a moderate -42.07%. Depreciation costs climbed by 6.49% quarter-on-quarter, whereas on an annual scale, they saw an increase of 0.31%. Profit before tax grew annually by 22.4% but saw a reduction from the preceding quarter by -4.63%.
Tax expenses as a percentage of profits increased slightly by 2.91% compared to last year, with a more notable quarter-on-quarter decrease of -2.84%. Net profit rose by 17.77% year-on-year but witnessed a -0.76% contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 17.71% but a quarterly fall of -0.8%. In summary, ROSSARI BIOTECH LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 406.47 Cr | Rs. 463.77 Cr | Rs. 472.72 Cr | + 1.93% | + 16.3% |
Expenses | Rs. 351.88 Cr | Rs. 400.1 Cr | Rs. 409.13 Cr | + 2.26% | + 16.27% |
Operating Profit | Rs. 54.59 Cr | Rs. 63.67 Cr | Rs. 63.59 Cr | -0.13% | + 16.49% |
Net Profit | Rs. 28.98 Cr | Rs. 34.39 Cr | Rs. 34.13 Cr | -0.76% | + 17.77% |
EPS in Rs | Rs. 5.25 | Rs. 6.23 | Rs. 6.18 | -0.8% | + 17.71% |
In reviewing ROSSARI BIOTECH LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 16.3 % year-on-year growth, however, there was a minor increase of 1.93% from the previous quarter. Expenses rose by 16.27% compared to the previous year, with a 2.26% increase quarter-on-quarter. Operating Profit surged by 16.49% annually, and saw a -0.13% decrease from the last quarter.
Net Profit showed yearly increase of 17.77%, and experienced a -0.76% decrease from the previous quarter.Earnings Per Share (EPS) rose by 17.71% annually, however dipped by -0.8% compared to the last quarter. In essence, while ROSSARI BIOTECH LIMITED exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.